This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) on December 13, 2024. The contract, valued at $2,360.58, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024 and is not set aside. Dakota Drug, Inc. is the prime contractor and does not have any major subcontractors listed. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.
Generated 3/14/25, 9:56 AM